We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Buys Biotech Firm With First-in-Class Compounds
Pfizer Buys Biotech Firm With First-in-Class Compounds
February 25, 2005
Drug giant Pfizer has signed a deal to acquire Idun Pharmaceuticals, a San Diego-based biopharmaceutical firm that owns more than 150 patents covering drug targets, new chemical entities, drug-screening assays, diagnostics and antibodies.